Early versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes.
Séverine VermeireJurij HanzelMark LöwenbergMarc FerrantePeter BossuytFrank HoentjenDenis FranchimontKároly PalatkaHarald PeetersAart MookhoekGert de HertoghTamás MolnárWouter van MoerkerckeTriana LobatónEsmé ClasquinMelanie S HulshoffFilip BaertGeert D'Haensnull nullPublished in: Journal of Crohn's & colitis (2023)
No significant differences in clinical, endoscopic, and histological outcomes were observed between "early" and "late" disease.